Leukocytoclastic Vasculitis Associated with HHV6-A/ciHHV6-A and HHV6-B Coinfection in an Immunocompetent Woman

Author(s): Agata Calvario*, Caterina Foti, Maria Scarasciulli, Paolo Romita, Eva Eliassen, Andrea Marzullo, Anna Maria Colacicco, Giuseppe Miragliotta.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 19 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background and Objective: Leukocytoclastic vasculitis (LCV) is a small vessel vasculitis that can be limited to the skin but may also affect other organs. Often, its cause is unknown. LCV has previously been reported to occur with the reactivation of human herpesvirus 6 (HHV-6). Here, we report a second instance of HHV-6 reactivation in a 43-year-old woman with idiopathic cutaneous LCV.

Case Description: In this case, the patient was immunocompetent, and testing revealed that she had inherited chromosomally integrated human herpesvirus 6 variant A (iciHHV6-A) with a parallel skin infection of HHV-6B. The integrated ciHHV-6A strain was found to be transcriptionally active in the blood, while HHV-6B late antigen was detected in a skin biopsy. The patient’s rash was not accompanied by fever nor systemic symptoms and resolved over four weeks without any therapeutic intervention.

Conclusion: In light of the transcriptional activity documented in our case, further examination of a possible role for HHV-6 in the etiology of LCV is warranted.

Keywords: HHV-6, ciHHV-6 reactivation, leukocytoclastic, vasculitis, LCV, Real-Time PCR.

[1]
Russell, J.P.; Gibson, L.E. Primary cutaneous small vessel vasculitis: Approach to diagnosis and treatment. Int. J. Dermatol., 2006, 45(1), 3-13.
[2]
Gyselbrecht, L.; De Keyser, F.; Ongenae, K.; Naeyaert, J.M.; Praet, M.; Veys, E.M. Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis. Clin. Exp. Rheumatol., 1996, 14(6), 665-668.
[3]
Drago, F.; Rampini, P.; Brusati, C.; Rebora, A. Leukocytoclastic vasculitis in a patient with HHV-6 infection. Acta Derm. Venereol., 2000, 80(1), 68.
[4]
Hashimoto, H.; Maruyama, H.; Fujimoto, K.; Sakakura, T.; Seishu, S.; Okuda, N. Hematologic findings associated with thrombocytopenia during the acute phase of exanthem subitum confirmed by primary human herpesvirus-6 infection. J. Pediatr. Hematol. Oncol., 2002, 24(3), 211-214.
[5]
Miura, H.; Kawamura, Y.; Ozeki, E.; Ihira, M.; Ohashi, M.; Yoshikawa, T. Pathogenesis of severe neutropenia in patients with primary human herpesvirus 6B infection. Pediatr. Infect. Dis. J., 2015, 34(9), 1003-1007.
[6]
Drago, F.; Broccolo, F.; Javor, S.; Drago, F.; Rebora, A.; Parodi, A. Evidence of human herpesvirus-6 and -7 reactivation in miscarrying women with pityriasis rosea. J. Am. Acad. Dermatol., 2014, 71(1), 198-199.
[7]
Pritchett, J.C.; Nanau, R.M.; Neuman, M.G. The link between hypersensitivity syndrome reaction development and human herpes virus-6 reactivation. Int. J. Hepatol., 2012, 2012, 723062.
[8]
Tohyama, M.; Hashimoto, K.; Yasukawa, M.; Kimura, H.; Horikawa, T.; Nakajima, K.; Urano, Y.; Matsumoto, K.; Iijima, M.; Shear, N.H. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br. J. Dermatol., 2007, 157(5), 934-940.
[9]
Miyagawa, F.; Nakamura, Y.; Miyashita, K.; Iioka, H.; Himuro, Y.; Ogawa, K.; Nishimura, C.; Nishikawa, M.; Mitsui, Y.; Ito, Y.; Ommori, R.; Mori, Y.; Asada, H. Preferential expression of CD134, an HHV-6 cellular receptor, on CD4T cells in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). J. Dermatol. Sci., 2016, 83(2), 151-154.
[10]
Pellett, P.E.; Ablashi, D.V.; Ambros, P.F.; Agut, H.; Caserta, M.T.; Descamps, V.; Flamand, L.; Gautheret-Dejean, A.; Hall, C.B.; Kamble, R.T.; Kuehl, U.; Lassner, D.; Lautenschlager, I.; Loomis, K.S.; Luppi, M.; Lusso, P.; Medveczky, P.G.; Montoya, J.G.; Mori, Y.; Ogata, M.; Pritchett, J.C.; Rogez, S.; Seto, E.; Ward, K.N.; Yoshikawa, T. Razonable, R.R. Chromosomally integrated human herpesvirus 6: Questions and answers. Rev. Med. Virol., 2012, 22(3), 144-155.
[11]
Ward, K.N.; Leong, H.N.; Nacheva, E.P.; Howard, J.; Atkinson, C.E.; Davies, N.W.; Griffiths, P.D.; Clark, D.A. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J. Clin. Microbiol., 2006, 44(4), 1571-1574.
[12]
Ablashi, D.; Agut, H.; Alvarez-Lafuente, R.; Clark, D.A.; Dewhurst, S.; DiLuca, D.; Flamand, L.; Frenkel, N.; Gallo, R.; Gompels, U.A.; Höllsberg, P.; Jacobson, S.; Luppi, M.; Lusso, P.; Malnati, M.; Medveczky, P.; Mori, Y.; Pellett, P.E.; Pritchett, J.C.; Yamanishi, K.; Yoshikawa, T. Classification of HHV-6A and HHV-6B as distinct viruses. Arch. Virol., 2014, 159(5), 863-870.
[13]
Arbuckle, J.H.; Medveczky, P.G. The molecular biology of human herpesvirus-6 latency and telomere integration. Microbes Infect., 2011, 13(8-9), 731-741.
[14]
Arbuckle, J.H.; Medveczky, M.M.; Luka, J.; Hadley, S.H.; Luegmayr, A.; Ablashi, D.; Lund, T.C.; Tolar, J.; Meirleir, K.D.; Montoya, J.G.; Komaroff, A.L.; Ambros, P.F.; Medveczky, P.G. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc. Natl. Acad. Sci. USA, 2010, 107(12), 5563-5568.
[15]
Zhang, E.; Bell, A.J.; Wilkie, G.S.; Suárez, N.M.; Batini, C.; Veal, C.D.; Armendáriz-Castillo, I.; Neumann, R.; Cotton, V.E.; Huang, Y.; Porteous, D.J.; Jarrett, R.F.; Davison, A.J.; Royle, N.J. Inherited chromosomally integrated human herpesvirus 6 genomes are ancient, intact and potentially able to reactivate from telomeres.J. Virol., 2017, 91(22), pii: e01137-e01117,
[16]
Endo, A.; Watanabe, K.; Ohye, T.; Suzuki, K.; Matsubara, T.; Shimizu, N.; Kurahashi, H.; Yoshikawa, T.; Katano, H.; Inoue, N.; Imai, K.; Takagi, M.; Morio, T.; Mizutani, S. Molecular and virological evidence of viral activation from chromosomally integrated human Herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. Clin. Infect. Dis., 2014, 59(4), 545-548.
[17]
Moustafa, A.; Xie, C.; Kirkness, E.; Biggs, W.; Wong, E.; Turpaz, Y.; Bloom, K.; Delwart, E.; Nelson, K.E.; Venter, J.C.; Telenti, A. The blood DNA virome in 8,000 humans. PLoS Pathog., 2017, 13(3), e1006292.
[18]
Hall, C.B.; Caserta, M.T.; Schnabel, K.C.; Shelley, L.M.; Carnahan, J.A.; Marino, A.S.; Yoo, C.; Lofthus, G.K. Transplacental human herpesvirus 6 (hhv-6) congenital infection caused by maternal chromosomally integrated virus. J. Infect. Dis., 2010, 201(4), 505-507.
[19]
Gravel, A.; Hall, C.B.; Flamand, L. Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus. J. Infect. Dis., 2013, 207(10), 1585-1589.
[20]
Gravel, A.; Dubuc, I.; Morissette, G.; Sedlak, R.H.; Jerome, K.R.; Flamand, L. Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris. Proc. Natl. Acad. Sci. USA, 2015, 112(26), 8058-8063.
[21]
Hill, J.A.; Magaret, A.S.; Hall-Sedlak, R.; Mikhaylova, A.; Huang, M.L.; Sandmaier, B.M.; Hansen, J.A.; Jerome, K.R.; Zerr, D.M.; Boeckh, M. Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6. Blood, 2017, 130(8), 1062-1069.
[22]
Hill, J.A.; Mayer, B.T.; Xie, H.; Leisenring, W.M.; Huang, M.L.; Stevens-Ayers, T.; Milano, F.; Delaney, C.; Sorror, M.L.; Sandmaier, B.M.; Nichols, G.; Zerr, D.M.; Jerome, K.R.; Schiffer, J.T.; Boeckh, M. The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. Blood, 2017, 129(16), 2316-2325.
[23]
Hall, C.B.; Long, C.E.; Schnabel, K.C.; Caserta, M.T.; McIntyre, K.M.; Costanzo, M.A.; Knott, A.; Dewhurst, S.; Insel, R.A.; Epstein, L.G. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med., 1994, 331(7), 432-438.
[24]
Epstein, L.G.; Shinnar, S.; Hesdorffer, D.C.; Nordli, D.R.; Hamidullah, A.; Benn, E.K.; Pellock, J.M.; Frank, L.M.; Lewis, D.V.; Moshe, S.L.; Shinnar, R.C.; Sun, S. Human herpesvirus 6 and 7 in febrile status epilepticus: The febstat study. Epileps, 2012, 53(9), 1481-1488.
[25]
Caselli, E.; Zatelli, M.C.; Rizzo, R.; Benedetti, S.; Martorelli, D.; Trasforini, G.; Cassai, E.; Uberti, E.C.; Luca, D.D.; Dolcetti, R. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS Pathog., 2012, 8(10), e1002951.
[26]
Marci, R.; Gentili, V.; Bortolotti, D.; Lo Monte, G.; Caselli, E.; Bolzani, S.; Rotola, A.; Luca, D.D.; Rizzo, R. Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One, 2016, 11(7), e0158304.
[27]
Cone, R.W.; Huang, M.L.; Hackman, R.C.; Corey, L. Coinfection with human herpesvirus 6 variants A and B in lung tissue. J. Clin. Microbiol., 1996, 34(4), 877-881.
[28]
Bajric, J.; Smith, W.M. A case of bilateral human herpes virus 6 panuveitis with genomic viral DNA integration. J. Ophthalmic Inflamm. Infect., 2014, 4-16.
[29]
Dagna, L.; Pritchett, J.C.; Lusso, P. Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol., 2013, 8(3), 273-287.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 2
Year: 2019
Page: [221 - 225]
Pages: 5
DOI: 10.2174/1871530318666181106153758
Price: $58

Article Metrics

PDF: 20
HTML: 2